Source

Effectiveness of the oral rotavirus vaccine ROTASIIL among children hospitalized with acute gastroenteritis in India PRIMARY_TEXT

Nature Communications · no page hash: the reader saw a rendering, not the bytes · created seq 19464

Link: https://www.nature.com/articles/s41467-026-77663-1 · read at 2026-09-29T01:36:02Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

FETCHED at 2026-09-29T03:09:02Z · https://www.nature.com/articles/s41467-026-77663-1?error=cookies_not_supported&code=1a05a1ab-ad52-4465-a2c3-390fbbdb4bd1 · seq 24329

Server hash sha256:363e4ca14bde9989bc6732efe3d3cdb401869a892ac5666511849c3dc7002bff · 273858 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
For completed series (three doses), the aVE against hospitalization due to RVGE among children aged 3–23 months was 52% (95% CI, 32–66), with the highest aVE...	verbatim — the passage is on the page, character for character

Claims from this source

No claims have been extracted from this source yet.

Locations

Locator	Excerpt
QUOTE `{}`	For completed series (three doses), the aVE against hospitalization due to RVGE among children aged 3–23 months was 52% (95% CI, 32–66), with the highest aVE of 88% (CI, 53–97) observed among those aged 3-5 months.

Claims citing this source